about
Spatial determinants of the alfalfa mosaic virus coat protein binding site.In vitro selection of ribozymes dependent on peptides for activityCellular protein modulates effects of human immunodeficiency virus type 1 RevResistance to RevM10 inhibition reflects a conformational switch in the HIV-1 Rev response element.The basic domain of Rev from human immunodeficiency virus type 1 specifically blocks the entry of U4/U6.U5 small nuclear ribonucleoprotein in spliceosome assemblyEukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activationHIV-1 Rev oligomerization is not obligatory in the presence of an extra basic domainEvaluation of methylphosphonates as analogs for detecting phosphate contacts in RNA-protein complexesAnalysis of the EIAV Rev-responsive element (RRE) reveals a conserved RNA motif required for high affinity Rev binding in both HIV-1 and EIAVRecruitment of the Crm1 nuclear export factor is sufficient to induce cytoplasmic expression of incompletely spliced human immunodeficiency virus mRNAsEffect of intercalator and Lewis acid-base branched peptide complex formation: boosting affinity towards HIV-1 RRE RNACharacterization and in vitro activity of a branched peptide boronic acid that interacts with HIV-1 RRE RNAThe HIV-1 Rev response element (RRE) adopts alternative conformations that promote different rates of virus replication.3D RNA and Functional Interactions from Evolutionary CouplingsA structured retroviral RNA element that mediates nucleocytoplasmic export of intron-containing RNASelection of RRE RNA binding peptides using a kanamycin antitermination assay.Thermodynamic profiling of HIV RREIIB RNA-zinc finger interactions.Bamboo mosaic potexvirus satellite RNA (satBaMV RNA)-encoded P20 protein preferentially binds to satBaMV RNAPolyvalent Rev decoys act as artificial Rev-responsive elements.Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-Domain- and nucleotide-specific Rev response element regulation of feline immunodeficiency virus production.Specificity of RSG-1.2 peptide binding to RRE-IIB RNA element of HIV-1 over Rev peptide is mainly enthalpic in origin.Functional analyses reveal extensive RRE plasticity in primary HIV-1 sequences selected under selective pressureThe binding site for ribosomal protein S8 in 16S rRNA and spc mRNA from Escherichia coli: minimum structural requirements and the effects of single bulged bases on S8-RNA interaction.Formation of trans-activation competent HIV-1 Rev:RRE complexes requires the recruitment of multiple protein activation domains.Sequence-specific interaction between HIV-1 matrix protein and viral genomic RNA revealed by in vitro genetic selection.Dynamics of the human and viral m(6)A RNA methylomes during HIV-1 infection of T cells.Mapping the RNA binding sites for human immunodeficiency virus type-1 gag and NC proteins within the complete HIV-1 and -2 untranslated leader regions.RNA tertiary structure of the HIV RRE domain II containing non-Watson-Crick base pairs GG and GA: molecular modeling studies.Targeting folded RNA: a branched peptide boronic acid that binds to a large surface area of HIV-1 RRE RNASelective optimization of the Rev-binding element of HIV-1.Coupled folding and specific binding: fishing for amphiphilicity.A peptide with alternating lysines can act as a highly specific Z-DNA binding domainHIV-1 drug discovery: targeting folded RNA structures with branched peptides.Nuclear export of the human immunodeficiency virus type 1 nucleocytoplasmic shuttle protein Rev is mediated by its activation domain and is blocked by transdominant negative mutantsRNA aptamers selected to bind human immunodeficiency virus type 1 Rev in vitro are Rev responsive in vivoMolding a peptide into an RNA site by in vivo peptide evolution.Comparative analysis of the structure and function of adenovirus virus-associated RNAs.Human immunodeficiency virus type 1 Rev activation can be achieved without Rev-responsive element RNA if Rev is directed to the target as a Rev/MS2 fusion protein which tethers the MS2 operator RNA.Design of beta-hairpin peptidomimetics that inhibit binding of alpha-helical HIV-1 Rev protein to the rev response element RNA.
P2860
Q24540235-D1583E9C-145F-4DD3-8D9D-10B353350BD6Q24540248-A686F445-6E95-41FD-8806-C85D82204831Q24646033-734E3950-8416-4393-B91D-97F343B7C19EQ24652856-8EB75A79-5BAC-4068-88A0-826C61D37B77Q24656044-2BFFCD6A-D663-4EEB-BC43-593582AB3233Q24657633-429ECB63-2A9D-4BB9-9FBB-F772A6EEF6EDQ24814560-8DCC1438-61CC-45D2-96DD-79673985E530Q28364705-C4076EF4-DD8E-4BF6-BBC0-E65526F749EBQ28472824-2761F812-DB0A-4FD5-AD08-3B841063D328Q28646696-FDA8620D-49E4-49DA-9BF8-496CE30F6942Q30276284-20DB1E4C-AD2A-4F85-B2EE-AC7D9091B6DAQ30276963-2702AFE6-DFE5-4B6B-8553-F5C0915E235FQ30300217-04FB1201-0CF4-4118-89AD-00D35A4ED62CQ30387020-870C0608-FF3F-4CF9-AEF5-47E2668F166DQ30452691-677A4990-59A3-4AEA-B202-E2B0FF25C1F2Q30884192-E7C6031B-6A0D-4D18-8F93-6166C7B8CAE5Q33489159-005A80C9-A700-42B2-96B1-E1024B28C3E7Q33644193-BF7C3AA6-311C-4340-B3FD-0DFDD4D13966Q33648134-39901539-F347-4F30-9C0A-DF3123E0CC15Q33866139-423DCE3D-9627-4040-B8B1-50603C365B1EQ33987860-08108A25-8E97-4BDF-80C9-E00059E8E6CFQ33997066-006C980E-63CF-43A7-9DED-2DCCB924774CQ34110556-8D10CFF1-8D03-422D-980B-CA2AAAD07B44Q34291829-71E30C86-BF4E-4E89-86BC-6D182DEC3BA6Q34295820-A73E6DD4-AAF8-485E-9184-07E2955B8C6DQ34363543-E2697083-2CD1-40BD-91CF-E56862D34696Q34538813-525477B5-960F-43F1-9C81-DA0301E30F0BQ34673247-E7D4A473-14AA-44F8-89AA-5868ECCCD92BQ34878902-6B0C8931-F7D3-4B53-8FEC-C54F77914F98Q34909697-4DC29CBD-DA78-4344-A934-82F4AA1231DEQ35019143-308EB57A-935F-4C4C-9DC7-17A74FFB080CQ35036023-1CC0440F-671C-416E-A59B-C1578BCF062DQ35128015-2BB57130-B685-4103-A8B2-EF61B82C758FQ35626292-EDB42163-1179-4169-924F-483E301B503FQ35839437-1EC69639-94BE-438E-B1FF-D8751C7905D4Q35853408-42ED2929-3A04-44A8-AC35-33D6C3E15547Q36625534-0F0593D4-1042-410D-81AC-D1655283B6C9Q36654374-962CA058-50F8-4FB9-A828-AAD759AF268FQ36687462-645DEF29-65FF-4905-8AB6-2D64F66FE398Q37259403-7E3B98A4-CEF0-47DE-9D26-62AC46ABD29B
P2860
description
1992 nî lūn-bûn
@nan
1992 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի մարտին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Specific binding of a basic peptide from HIV-1 Rev.
@ast
Specific binding of a basic peptide from HIV-1 Rev.
@en
type
label
Specific binding of a basic peptide from HIV-1 Rev.
@ast
Specific binding of a basic peptide from HIV-1 Rev.
@en
prefLabel
Specific binding of a basic peptide from HIV-1 Rev.
@ast
Specific binding of a basic peptide from HIV-1 Rev.
@en
P2093
P2860
P1433
P1476
Specific binding of a basic peptide from HIV-1 Rev.
@en
P2093
P2860
P304
P407
P577
1992-03-01T00:00:00Z